List of Excipients in API nateglinide
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing nateglinide
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Novartis Pharmaceuticals Corporation | STARLIX | nateglinide | 0078-0351 | CELLULOSE, MICROCRYSTALLINE | |
| Novartis Pharmaceuticals Corporation | STARLIX | nateglinide | 0078-0351 | CROSCARMELLOSE SODIUM | |
| Novartis Pharmaceuticals Corporation | STARLIX | nateglinide | 0078-0351 | FERRIC OXIDE RED | |
| Novartis Pharmaceuticals Corporation | STARLIX | nateglinide | 0078-0351 | HYPROMELLOSE 2208 | |
| Novartis Pharmaceuticals Corporation | STARLIX | nateglinide | 0078-0351 | LACTOSE MONOHYDRATE | |
| Novartis Pharmaceuticals Corporation | STARLIX | nateglinide | 0078-0351 | MAGNESIUM STEARATE | |
| Novartis Pharmaceuticals Corporation | STARLIX | nateglinide | 0078-0351 | POLYETHYLENE GLYCOL | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing nateglinide
| Company | Ingredient | NDC | Excipient |
|---|---|---|---|
| Actavis Pharma Inc | nateglinide | 0591-3354 | FD&C RED NO. 40 |
| Actavis Pharma Inc | nateglinide | 0591-3354 | FERRIC OXIDE RED |
| Actavis Pharma Inc | nateglinide | 0591-3354 | FERROSOFERRIC OXIDE |
| Actavis Pharma Inc | nateglinide | 0591-3354 | FUMARIC ACID |
| Actavis Pharma Inc | nateglinide | 0591-3354 | HYPROMELLOSE 2910 |
| Actavis Pharma Inc | nateglinide | 0591-3354 | LACTOSE MONOHYDRATE |
| Actavis Pharma Inc | nateglinide | 0591-3354 | MAGNESIUM STEARATE |
| >Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for nateglinide
Excipient focus: ANHYDROUS CITRIC ACID
nateglinide drug variants containing ANHYDROUS CITRIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Zydus Pharmaceuticals USA Inc | nateglinide | 68382-721 |
| Zydus Lifesciences Limited | nateglinide | 70771-1015 |
| >Company | >Ingredient | >NDC |
nateglinide drug variants not containing ANHYDROUS CITRIC ACID
Excipient focus: CARNAUBA WAX
nateglinide drug variants containing CARNAUBA WAX
| Company | Ingredient | NDC |
|---|---|---|
| Dr Reddy's Laboratories Limited | nateglinide | 55111-328 |
| >Company | >Ingredient | >NDC |
nateglinide drug variants not containing CARNAUBA WAX
Excipient focus: CELLULOSE, MICROCRYSTALLINE
nateglinide drug variants containing CELLULOSE, MICROCRYSTALLINE
nateglinide drug variants not containing CELLULOSE, MICROCRYSTALLINE
Excipient focus: COLLOIDAL SILICON DIOXIDE
nateglinide drug variants containing COLLOIDAL SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | nateglinide | 54868-6255 |
| >Company | >Ingredient | >NDC |
nateglinide drug variants not containing COLLOIDAL SILICON DIOXIDE
Excipient focus: COPOVIDONE
nateglinide drug variants containing COPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Dr Reddy's Laboratories Limited | nateglinide | 55111-328 |
| >Company | >Ingredient | >NDC |
nateglinide drug variants not containing COPOVIDONE
Excipient focus: CROSCARMELLOSE SODIUM
nateglinide drug variants containing CROSCARMELLOSE SODIUM
nateglinide drug variants not containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | nateglinide | 0591-3354 |
| Rising Pharmaceuticals Inc | nateglinide | 16571-758 |
| Wilshire Pharmaceuticals Inc | nateglinide | 52536-063 |
| Zydus Pharmaceuticals USA Inc | nateglinide | 68382-721 |
| Zydus Lifesciences Limited | nateglinide | 70771-1015 |
| >Company | >Ingredient | >NDC |
Excipient focus: CROSPOVIDONE
nateglinide drug variants containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Zydus Pharmaceuticals USA Inc | nateglinide | 68382-721 |
| Zydus Lifesciences Limited | nateglinide | 70771-1015 |
| >Company | >Ingredient | >NDC |
nateglinide drug variants not containing CROSPOVIDONE
Excipient focus: FD&C RED NO. 40
nateglinide drug variants containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | nateglinide | 0591-3354 |
| >Company | >Ingredient | >NDC |
nateglinide drug variants not containing FD&C RED NO. 40
Excipient focus: FD&C YELLOW NO. 6
nateglinide drug variants containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | nateglinide | 54868-6255 |
| >Company | >Ingredient | >NDC |
nateglinide drug variants not containing FD&C YELLOW NO. 6
Excipient focus: FERRIC OXIDE RED
nateglinide drug variants containing FERRIC OXIDE RED
nateglinide drug variants not containing FERRIC OXIDE RED
Excipient focus: FERROSOFERRIC OXIDE
nateglinide drug variants containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | nateglinide | 0591-3354 |
| >Company | >Ingredient | >NDC |
nateglinide drug variants not containing FERROSOFERRIC OXIDE
Excipient focus: FUMARIC ACID
nateglinide drug variants containing FUMARIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | nateglinide | 0591-3354 |
| >Company | >Ingredient | >NDC |
nateglinide drug variants not containing FUMARIC ACID
Excipient focus: HYPROMELLOSE
nateglinide drug variants containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Rising Pharmaceuticals Inc | nateglinide | 16571-758 |
| Wilshire Pharmaceuticals Inc | nateglinide | 52536-063 |
| Nivagen Pharmaceuticals Inc | nateglinide | 75834-205 |
| >Company | >Ingredient | >NDC |
nateglinide drug variants not containing HYPROMELLOSE
Excipient focus: HYPROMELLOSE 2208
nateglinide drug variants containing HYPROMELLOSE 2208
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | nateglinide | 0078-0351 |
| >Company | >Ingredient | >NDC |
nateglinide drug variants not containing HYPROMELLOSE 2208
Excipient focus: HYPROMELLOSE 2910
nateglinide drug variants containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | nateglinide | 0591-3354 |
| >Company | >Ingredient | >NDC |
nateglinide drug variants not containing HYPROMELLOSE 2910
Excipient focus: HYPROMELLOSES
nateglinide drug variants containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| Zydus Pharmaceuticals USA Inc | nateglinide | 68382-721 |
| Zydus Lifesciences Limited | nateglinide | 70771-1015 |
| Cadila Pharmaceuticals Limited | nateglinide | 71209-030 |
| Modavar Pharmaceuticals LLC | nateglinide | 72241-002 |
| >Company | >Ingredient | >NDC |
nateglinide drug variants not containing HYPROMELLOSES
Excipient focus: LACTOSE MONOHYDRATE
nateglinide drug variants containing LACTOSE MONOHYDRATE
nateglinide drug variants not containing LACTOSE MONOHYDRATE
Excipient focus: MAGNESIUM STEARATE
nateglinide drug variants containing MAGNESIUM STEARATE
nateglinide drug variants not containing MAGNESIUM STEARATE
Excipient focus: MANNITOL
nateglinide drug variants containing MANNITOL
nateglinide drug variants not containing MANNITOL
Excipient focus: POLYETHYLENE GLYCOL
nateglinide drug variants containing POLYETHYLENE GLYCOL
nateglinide drug variants not containing POLYETHYLENE GLYCOL
Excipient focus: POLYETHYLENE GLYCOL 6000
nateglinide drug variants containing POLYETHYLENE GLYCOL 6000
| Company | Ingredient | NDC |
|---|---|---|
| Cadila Pharmaceuticals Limited | nateglinide | 71209-030 |
| Modavar Pharmaceuticals LLC | nateglinide | 72241-002 |
| Nivagen Pharmaceuticals Inc | nateglinide | 75834-205 |
| >Company | >Ingredient | >NDC |
nateglinide drug variants not containing POLYETHYLENE GLYCOL 6000
Excipient focus: POLYETHYLENE GLYCOLS
nateglinide drug variants containing POLYETHYLENE GLYCOLS
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY Inc dba Vangard Labs | nateglinide | 0615-7585 |
| >Company | >Ingredient | >NDC |
nateglinide drug variants not containing POLYETHYLENE GLYCOLS
Excipient focus: POLYSORBATE 80
nateglinide drug variants containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | nateglinide | 0591-3354 |
| Zydus Pharmaceuticals USA Inc | nateglinide | 68382-721 |
| Zydus Lifesciences Limited | nateglinide | 70771-1015 |
| >Company | >Ingredient | >NDC |
nateglinide drug variants not containing POLYSORBATE 80
Excipient focus: POLYVINYL ALCOHOL
nateglinide drug variants containing POLYVINYL ALCOHOL
nateglinide drug variants not containing POLYVINYL ALCOHOL
Excipient focus: POVIDONE
nateglinide drug variants containing POVIDONE
nateglinide drug variants not containing POVIDONE
Excipient focus: POVIDONE K12
nateglinide drug variants containing POVIDONE K12
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY Inc dba Vangard Labs | nateglinide | 0615-7585 |
| >Company | >Ingredient | >NDC |
nateglinide drug variants not containing POVIDONE K12
Excipient focus: POVIDONE K30
nateglinide drug variants containing POVIDONE K30
| Company | Ingredient | NDC |
|---|---|---|
| Rising Pharmaceuticals Inc | nateglinide | 16571-758 |
| Wilshire Pharmaceuticals Inc | nateglinide | 52536-063 |
| Cadila Pharmaceuticals Limited | nateglinide | 71209-030 |
| Modavar Pharmaceuticals LLC | nateglinide | 72241-002 |
| Nivagen Pharmaceuticals Inc | nateglinide | 75834-205 |
| >Company | >Ingredient | >NDC |
nateglinide drug variants not containing POVIDONE K30
Excipient focus: SILICON DIOXIDE
nateglinide drug variants containing SILICON DIOXIDE
nateglinide drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | nateglinide | 54868-6255 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM LAURYL SULFATE
nateglinide drug variants containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Dr Reddy's Laboratories Limited | nateglinide | 55111-328 |
| Cadila Pharmaceuticals Limited | nateglinide | 71209-030 |
| Modavar Pharmaceuticals LLC | nateglinide | 72241-002 |
| Nivagen Pharmaceuticals Inc | nateglinide | 75834-205 |
| >Company | >Ingredient | >NDC |
nateglinide drug variants not containing SODIUM LAURYL SULFATE
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
nateglinide drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
nateglinide drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
Excipient focus: SODIUM STEARYL FUMARATE
nateglinide drug variants containing SODIUM STEARYL FUMARATE
nateglinide drug variants not containing SODIUM STEARYL FUMARATE
Excipient focus: STARCH, CORN
nateglinide drug variants containing STARCH, CORN
nateglinide drug variants not containing STARCH, CORN
Excipient focus: TALC
nateglinide drug variants containing TALC
nateglinide drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | nateglinide | 0591-3354 |
| Physicians Total Care Inc | nateglinide | 54868-6255 |
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
nateglinide drug variants containing TITANIUM DIOXIDE
nateglinide drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | nateglinide | 54868-6255 |
| Dr Reddy's Laboratories Limited | nateglinide | 55111-328 |
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
